Biotechnology
The Biotechnology industry has a total of 607 stocks, with a combined market cap of $1.1 trillion and total revenue of $105.24 billion.
Market Cap
1.1T
Revenue
105.24B
Profits
-42.71B
PE Ratio
n/a
Profit Margin
-40.58%
Dividend Yield
0.04%
607 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 107.98B | -1.85% | 1,143,048 | 11.72B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 76.96B | -3.86% | 976,796 | 14.25B |
| 3 | ALNY | Alnylam Pharmaceuticals, Inc. | 60.05B | 0.74% | 1,070,640 | 3.21B |
| 4 | ARGX | argenx SE | 54.94B | -1.87% | 355,435 | 3.68B |
| 5 | INSM | Insmed Incorporated | 45.09B | 1.75% | 1,860,509 | 447.02M |
| 6 | ONC | BeOne Medicines AG | 37.17B | -1.39% | 198,631 | 5.00B |
| 7 | BNTX | BioNTech SE | 23.42B | -5.58% | 1,760,296 | 3.70B |
| 8 | RPRX | Royalty Pharma plc | 23.03B | -0.30% | 3,897,529 | 2.35B |
| 9 | INCY | Incyte Corporation | 20.03B | -2.32% | 2,252,027 | 4.81B |
| 10 | GMAB | Genmab A/S | 19.59B | -3.00% | 1,418,200 | 3.85B |
| 11 | RVMD | Revolution Medicines, Inc. | 14.65B | -2.52% | 1,649,261 | - |
| 12 | ROIV | Roivant Sciences Ltd. | 14.06B | -2.84% | 7,984,782 | 20.33M |
| 13 | BBIO | BridgeBio Pharma, Inc. | 13.84B | -0.24% | 2,378,951 | 353.78M |
| 14 | SMMT | Summit Therapeutics Inc. | 13.31B | -3.52% | 1,895,290 | - |
| 15 | IONS | Ionis Pharmaceuticals, Inc. | 13.28B | -0.89% | 1,865,369 | 966.96M |
| 16 | MDGL | Madrigal Pharmaceuticals, Inc. | 13.16B | -2.94% | 298,129 | 740.64M |
| 17 | ASND | Ascendis Pharma A/S | 12.88B | -0.70% | 492,336 | 758.59M |
| 18 | EXEL | Exelixis, Inc. | 11.69B | -1.68% | 2,477,338 | 2.29B |
| 19 | RNA | Avidity Biosciences, Inc. | 10.75B | -0.49% | 2,057,143 | 20.87M |
| 20 | BMRN | BioMarin Pharmaceutical Inc. | 10.57B | -1.61% | 2,339,482 | 3.09B |
| 21 | JAZZ | Jazz Pharmaceuticals plc | 10.46B | -2.50% | 1,524,474 | 4.16B |
| 22 | TECH | Bio-Techne Corporation | 9.94B | -1.12% | 1,550,235 | 1.22B |
| 23 | MRNA | Moderna, Inc. | 9.44B | -7.01% | 9,587,044 | 2.23B |
| 24 | ABVX | ABIVAX Société Anonyme | 9.33B | -3.93% | 904,842 | 7.07M |
| 25 | CORT | Corcept Therapeutics Incorporated | 8.39B | 0.48% | 899,977 | 741.17M |
| 26 | NUVL | Nuvalent, Inc. | 8.26B | -2.68% | 1,076,860 | - |
| 27 | CYTK | Cytokinetics, Incorporated | 8.08B | -3.05% | 1,396,351 | 87.21M |
| 28 | HALO | Halozyme Therapeutics, Inc. | 8.01B | -4.62% | 2,252,249 | 1.24B |
| 29 | ARWR | Arrowhead Pharmaceuticals, Inc. | 7.64B | 6.74% | 3,323,774 | 829.45M |
| 30 | AXSM | Axsome Therapeutics, Inc. | 7.51B | -1.63% | 499,014 | 561.26M |
| 31 | CAI | Caris Life Sciences, Inc. | 7.35B | 2.04% | 4,384,934 | 649.06M |
| 32 | MRUS | Merus N.V. | 7.28B | -0.21% | 1,508,384 | 56.61M |
| 33 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.01B | -3.71% | 884,488 | 174.33M |
| 34 | CDTX | Cidara Therapeutics, Inc. | 6.91B | -0.06% | 2,349,307 | 302.00K |
| 35 | PTCT | PTC Therapeutics, Inc. | 6.36B | -7.90% | 2,888,993 | 1.78B |
| 36 | KRYS | Krystal Biotech, Inc. | 6.24B | -1.33% | 218,206 | 373.16M |
| 37 | COGT | Cogent Biosciences, Inc. | 6.05B | -1.14% | 1,735,513 | - |
| 38 | PCVX | Vaxcyte, Inc. | 5.96B | -8.24% | 3,065,771 | - |
| 39 | BLTE | Belite Bio, Inc | 5.37B | 12.06% | 752,782 | - |
| 40 | PTGX | Protagonist Therapeutics, Inc. | 5.35B | -4.84% | 1,081,160 | 209.22M |
| 41 | CRSP | CRISPR Therapeutics AG | 4.97B | -2.43% | 2,286,060 | 38.34M |
| 42 | LEGN | Legend Biotech Corporation | 4.96B | -3.14% | 1,413,442 | 909.05M |
| 43 | KYMR | Kymera Therapeutics, Inc. | 4.81B | -1.50% | 616,408 | 43.74M |
| 44 | APGE | Apogee Therapeutics, Inc. | 4.65B | -4.25% | 651,527 | - |
| 45 | TGTX | TG Therapeutics, Inc. | 4.63B | -4.78% | 1,583,412 | 531.90M |
| 46 | PRAX | Praxis Precision Medicines, Inc. | 4.62B | -6.06% | 904,935 | 7.46M |
| 47 | ADMA | ADMA Biologics, Inc. | 4.61B | 1.04% | 3,756,678 | 488.56M |
| 48 | CELC | Celcuity Inc. | 4.56B | -2.63% | 755,801 | - |
| 49 | NAMS | NewAmsterdam Pharma Company N.V. | 4.49B | -4.02% | 820,042 | 35.24M |
| 50 | AKRO | Akero Therapeutics, Inc. | 4.48B | 0.14% | 1,993,588 | - |
| 51 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.29B | -0.68% | 986,655 | 1.54M |
| 52 | SRRK | Scholar Rock Holding Corporation | 4.28B | -4.70% | 1,997,235 | - |
| 53 | ACAD | ACADIA Pharmaceuticals Inc. | 4.21B | -0.68% | 1,077,050 | 1.05B |
| 54 | CNTA | Centessa Pharmaceuticals plc | 4.16B | -1.93% | 1,288,804 | 15.00M |
| 55 | ACLX | Arcellx, Inc. | 4.06B | -3.34% | 1,025,218 | 35.90M |
| 56 | IMVT | Immunovant, Inc. | 3.99B | -5.80% | 1,314,915 | - |
| 57 | VKTX | Viking Therapeutics, Inc. | 3.91B | -6.14% | 2,330,719 | - |
| 58 | ARQT | Arcutis Biotherapeutics, Inc. | 3.72B | -0.91% | 1,575,526 | 317.93M |
| 59 | MIRM | Mirum Pharmaceuticals, Inc. | 3.60B | -4.16% | 930,953 | 471.79M |
| 60 | CGON | CG Oncology, Inc. | 3.49B | -3.55% | 793,132 | 2.17M |
| 61 | IRON | Disc Medicine, Inc. | 3.46B | -1.79% | 603,732 | - |
| 62 | TARS | Tarsus Pharmaceuticals, Inc. | 3.40B | 0.03% | 395,846 | 366.10M |
| 63 | XENE | Xenon Pharmaceuticals Inc. | 3.36B | -2.71% | 815,751 | 7.50M |
| 64 | TLX | Telix Pharmaceuticals Limited | 3.34B | -1.46% | 67,164 | 664.23M |
| 65 | RCUS | Arcus Biosciences, Inc. | 3.23B | - | 2,620,217 | 240.00M |
| 66 | MLYS | Mineralys Therapeutics, Inc. | 3.22B | -5.52% | 1,542,800 | - |
| 67 | RARE | Ultragenyx Pharmaceutical Inc. | 3.21B | -3.97% | 1,042,360 | 630.60M |
| 68 | TVTX | Travere Therapeutics, Inc. | 3.15B | -0.65% | 1,288,377 | 435.83M |
| 69 | FOLD | Amicus Therapeutics, Inc. | 3.02B | -1.31% | 6,215,095 | 598.70M |
| 70 | AAPG | Ascentage Pharma Group International | 3.01B | 0.89% | 598 | 54.52M |
| 71 | IDYA | IDEAYA Biosciences, Inc. | 3.01B | -3.82% | 601,772 | 214.83M |
| 72 | VRDN | Viridian Therapeutics, Inc. | 3.00B | -1.60% | 1,124,559 | 70.79M |
| 73 | DYN | Dyne Therapeutics, Inc. | 2.94B | -5.89% | 1,593,710 | - |
| 74 | ADPT | Adaptive Biotechnologies Corporation | 2.88B | -4.17% | 1,943,873 | 252.75M |
| 75 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.79B | -3.08% | 1,184,124 | 578.20M |
| 76 | LQDA | Liquidia Corporation | 2.79B | -1.78% | 1,089,753 | 69.22M |
| 77 | NUVB | Nuvation Bio Inc. | 2.70B | -1.87% | 5,162,312 | 26.75M |
| 78 | APLS | Apellis Pharmaceuticals, Inc. | 2.68B | -0.47% | 1,557,777 | 1.02B |
| 79 | EWTX | Edgewise Therapeutics, Inc. | 2.68B | -2.96% | 964,127 | - |
| 80 | DNLI | Denali Therapeutics Inc. | 2.66B | -6.73% | 1,539,320 | - |
| 81 | SLNO | Soleno Therapeutics, Inc. | 2.63B | -2.83% | 1,838,305 | 98.68M |
| 82 | OCUL | Ocular Therapeutix, Inc. | 2.49B | -3.62% | 2,024,539 | 55.78M |
| 83 | TERN | Terns Pharmaceuticals, Inc. | 2.48B | -2.06% | 2,707,097 | - |
| 84 | BEAM | Beam Therapeutics Inc. | 2.37B | -5.05% | 1,851,120 | 55.70M |
| 85 | RXRX | Recursion Pharmaceuticals, Inc. | 2.27B | -5.83% | 18,143,598 | 43.69M |
| 86 | IBRX | ImmunityBio, Inc. | 2.27B | -2.54% | 19,318,425 | 82.56M |
| 87 | MESO | Mesoblast Limited | 2.24B | -1.33% | 237,184 | 17.20M |
| 88 | SYRE | Spyre Therapeutics, Inc. | 2.22B | -4.47% | 862,129 | - |
| 89 | ZLAB | Zai Lab Limited | 2.20B | -2.60% | 676,957 | 441.63M |
| 90 | OLMA | Olema Pharmaceuticals, Inc. | 2.20B | -1.31% | 2,156,544 | - |
| 91 | AUPH | Aurinia Pharmaceuticals Inc. | 2.13B | 0.31% | 2,014,391 | 265.81M |
| 92 | VERA | Vera Therapeutics, Inc. | 2.11B | -2.22% | 983,192 | - |
| 93 | GPCR | Structure Therapeutics Inc. | 2.10B | -3.46% | 673,418 | - |
| 94 | SRPT | Sarepta Therapeutics, Inc. | 2.07B | -7.59% | 2,843,149 | 2.41B |
| 95 | GLPG | Galapagos NV | 2.05B | -0.51% | 125,594 | 336.64M |
| 96 | HRMY | Harmony Biosciences Holdings, Inc. | 2.05B | 0.62% | 638,904 | 825.94M |
| 97 | JANX | Janux Therapeutics, Inc. | 2.04B | -0.29% | 3,218,460 | 10.00M |
| 98 | ZBIO | Zenas BioPharma, Inc. | 1.99B | -4.53% | 271,176 | 15.00M |
| 99 | VCEL | Vericel Corporation | 1.96B | -3.55% | 421,972 | 258.72M |
| 100 | ZYME | Zymeworks Inc. | 1.95B | -2.55% | 830,232 | 134.48M |
| 101 | IMCR | Immunocore Holdings plc | 1.90B | -4.84% | 304,659 | 379.59M |
| 102 | DNTH | Dianthus Therapeutics, Inc. | 1.85B | -1.77% | 706,999 | 3.08M |
| 103 | MAZE | Maze Therapeutics, Inc. | 1.81B | -0.44% | 478,701 | 2.50M |
| 104 | SION | Sionna Therapeutics, Inc. | 1.74B | -10.58% | 710,934 | - |
| 105 | CLDX | Celldex Therapeutics, Inc. | 1.72B | -4.03% | 463,198 | 2.60M |
| 106 | STOK | Stoke Therapeutics, Inc. | 1.72B | -2.65% | 732,083 | 205.63M |
| 107 | NRIX | Nurix Therapeutics, Inc. | 1.71B | -4.36% | 1,914,377 | 83.69M |
| 108 | TRVI | Trevi Therapeutics, Inc. | 1.71B | 1.06% | 3,025,684 | - |
| 109 | PHVS | Pharvaris N.V. | 1.69B | -8.39% | 367,954 | - |
| 110 | IMNM | Immunome, Inc. | 1.68B | -0.65% | 808,353 | 9.68M |
| 111 | MNKD | MannKind Corporation | 1.67B | 1.50% | 2,668,130 | 313.79M |
| 112 | SNDX | Syndax Pharmaceuticals, Inc. | 1.66B | -3.53% | 1,646,800 | 111.30M |
| 113 | QURE | uniQure N.V. | 1.66B | -3.42% | 1,335,735 | 15.75M |
| 114 | AGIO | Agios Pharmaceuticals, Inc. | 1.62B | -4.66% | 1,501,322 | 44.79M |
| 115 | INVA | Innoviva, Inc. | 1.58B | -2.62% | 706,421 | 388.52M |
| 116 | UPB | Upstream Bio, Inc. | 1.56B | 1.19% | 418,237 | 2.80M |
| 117 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.56B | -4.94% | 975,137 | -665.00K |
| 118 | MBX | MBX Biosciences, Inc. | 1.48B | -4.32% | 645,103 | - |
| 119 | SVRA | Savara Inc. | 1.41B | -7.15% | 3,707,602 | - |
| 120 | TNGX | Tango Therapeutics, Inc. | 1.40B | -4.63% | 2,016,795 | 66.50M |
| 121 | RAPP | Rapport Therapeutics, Inc. | 1.36B | -3.90% | 288,096 | - |
| 122 | ARDX | Ardelyx, Inc. | 1.36B | -3.62% | 2,601,189 | 398.23M |
| 123 | ORKA | Oruka Therapeutics, Inc. | 1.34B | -8.07% | 488,636 | - |
| 124 | URGN | UroGen Pharma Ltd. | 1.33B | -1.18% | 806,804 | 96.52M |
| 125 | RLAY | Relay Therapeutics, Inc. | 1.28B | -6.57% | 1,126,956 | 8.36M |
| 126 | PGEN | Precigen, Inc. | 1.28B | -5.74% | 3,147,647 | 6.31M |
| 127 | IMTX | Immatics N.V. | 1.25B | -3.93% | 438,071 | 99.45M |
| 128 | NKTR | Nektar Therapeutics | 1.24B | -6.29% | 477,643 | 62.60M |
| 129 | WVE | Wave Life Sciences Ltd. | 1.24B | -4.38% | 1,702,430 | 109.23M |
| 130 | SEPN | Septerna, Inc. | 1.24B | -5.07% | 285,884 | 22.05M |
| 131 | BHVN | Biohaven Ltd. | 1.24B | -7.08% | 2,469,968 | - |
| 132 | TSHA | Taysha Gene Therapies, Inc. | 1.21B | -6.54% | 2,375,709 | 6.31M |
| 133 | MNMD | Mind Medicine (MindMed) Inc. | 1.21B | -3.08% | 1,046,140 | - |
| 134 | EYPT | EyePoint Pharmaceuticals, Inc. | 1.18B | -3.84% | 697,119 | 42.34M |
| 135 | XNCR | Xencor, Inc. | 1.18B | -4.62% | 496,786 | 150.13M |
| 136 | ELVN | Enliven Therapeutics, Inc. | 1.18B | -8.10% | 496,203 | - |
| 137 | INBX | Inhibrx Biosciences, Inc. | 1.17B | -3.98% | 163,929 | 1.40M |
| 138 | CVAC | CureVac N.V. | 1.17B | -5.28% | 7,238,713 | 83.00M |
| 139 | KOD | Kodiak Sciences Inc. | 1.16B | -4.53% | 697,127 | - |
| 140 | XERS | Xeris Biopharma Holdings, Inc. | 1.15B | -3.06% | 1,781,986 | 266.14M |
| 141 | FTRE | Fortrea Holdings Inc. | 1.15B | -1.97% | 806,005 | 2.76B |
| 142 | ANAB | AnaptysBio, Inc. | 1.14B | -0.82% | 567,692 | 169.47M |
| 143 | PVLA | Palvella Therapeutics, Inc. | 1.12B | -8.04% | 175,657 | - |
| 144 | TYRA | Tyra Biosciences, Inc. | 1.11B | -7.76% | 391,562 | - |
| 145 | PHAR | Pharming Group N.V. | 1.10B | -4.17% | 22,075 | 362.27M |
| 146 | OCS | Oculis Holding AG | 1.10B | - | 134,872 | 992.00K |
| 147 | NVAX | Novavax, Inc. | 1.09B | -5.11% | 2,685,764 | 1.06B |
| 148 | ORIC | ORIC Pharmaceuticals, Inc. | 1.09B | -6.14% | 1,141,142 | - |
| 149 | SANA | Sana Biotechnology, Inc. | 1.07B | -6.98% | 5,415,959 | - |
| 150 | PHAT | Phathom Pharmaceuticals, Inc. | 1.04B | -4.35% | 1,130,726 | 147.19M |
| 151 | ABCL | AbCellera Biologics Inc. | 1.04B | -6.97% | 3,927,020 | 35.33M |
| 152 | GLUE | Monte Rosa Therapeutics, Inc. | 1.03B | -2.41% | 545,710 | 181.54M |
| 153 | NBTX | Nanobiotix S.A. | 997.71M | 0.80% | 31,179 | 11.93M |
| 154 | KURA | Kura Oncology, Inc. | 995.48M | -5.77% | 1,390,256 | 104.03M |
| 155 | TBPH | Theravance Biopharma, Inc. | 993.69M | -3.40% | 624,366 | 80.33M |
| 156 | MDXG | MiMedx Group, Inc. | 987.84M | -3.05% | 580,069 | 393.44M |
| 157 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 976.66M | -0.81% | 163,805 | - |
| 158 | NTLA | Intellia Therapeutics, Inc. | 975.29M | -6.34% | 4,515,500 | 57.53M |
| 159 | CMPX | Compass Therapeutics, Inc. | 971.13M | -5.86% | 3,195,364 | 850.00K |
| 160 | LENZ | LENZ Therapeutics, Inc. | 951.22M | -0.39% | 639,497 | 17.50M |
| 161 | BCAX | Bicara Therapeutics Inc. | 949.37M | -6.63% | 562,203 | - |
| 162 | MLTX | MoonLake Immunotherapeutics | 945.70M | -3.50% | 1,647,645 | - |
| 163 | AVBP | ArriVent BioPharma, Inc. | 929.66M | -1.83% | 350,865 | - |
| 164 | SPRY | ARS Pharmaceuticals, Inc. | 929.18M | -1.47% | 1,146,439 | 142.77M |
| 165 | DAWN | Day One Biopharmaceuticals, Inc. | 901.49M | -7.48% | 1,410,571 | 133.67M |
| 166 | IOVA | Iovance Biotherapeutics, Inc. | 885.24M | -9.72% | 11,790,132 | 250.43M |
| 167 | YDES | YD Bio Limited | 879.00M | 8.41% | 123,833 | 510.36K |
| 168 | GHRS | GH Research PLC | 878.03M | -6.63% | 162,943 | - |
| 169 | RAPT | RAPT Therapeutics, Inc. | 873.17M | -6.78% | 217,566 | - |
| 170 | MRVI | Maravai LifeSciences Holdings, Inc. | 864.29M | -6.63% | 1,582,095 | 192.44M |
| 171 | RIGL | Rigel Pharmaceuticals, Inc. | 857.83M | -6.40% | 587,780 | 282.08M |
| 172 | ERAS | Erasca, Inc. | 851.14M | -5.36% | 1,273,298 | - |
| 173 | RZLT | Rezolute, Inc. | 850.31M | -5.66% | 2,281,930 | - |
| 174 | VIR | Vir Biotechnology, Inc. | 844.49M | -5.45% | 2,719,228 | 16.86M |
| 175 | ATAI | Atai Beckley N.V. | 823.06M | -1.29% | 2,942,496 | 3.02M |
| 176 | ABUS | Arbutus Biopharma Corporation | 809.68M | -4.54% | 772,056 | 14.61M |
| 177 | VSTM | Verastem, Inc. | 798.06M | -2.82% | 2,248,075 | 13.38M |
| 178 | VALN | Valneva SE | 773.41M | -4.76% | 14,527 | 211.09M |
| 179 | CRMD | CorMedix Inc. | 771.34M | -0.20% | 1,918,072 | 214.30M |
| 180 | ALMS | Alumis Inc. | 767.29M | -4.17% | 1,014,049 | 22.12M |
| 181 | REPL | Replimune Group, Inc. | 761.68M | -2.90% | 1,370,109 | - |
| 182 | GERN | Geron Corporation | 759.64M | 0.85% | 6,427,872 | 183.40M |
| 183 | ARVN | Arvinas, Inc. | 758.49M | -6.16% | 1,152,132 | 312.30M |
| 184 | CTMX | CytomX Therapeutics, Inc. | 726.88M | 0.23% | 2,862,862 | 113.63M |
| 185 | GOSS | Gossamer Bio, Inc. | 726.77M | -5.99% | 3,588,173 | 44.05M |
| 186 | ATXS | Astria Therapeutics, Inc. | 720.41M | -0.24% | 747,561 | 706.00K |
| 187 | KALV | KalVista Pharmaceuticals, Inc. | 702.85M | -3.90% | 743,416 | 1.43M |
| 188 | GYRE | Gyre Therapeutics, Inc. | 697.13M | -1.03% | 53,180 | 107.27M |
| 189 | OMER | Omeros Corporation | 686.32M | -0.10% | 2,571,740 | - |
| 190 | PROK | ProKidney Corp. | 679.89M | 1.80% | 1,136,983 | 744.00K |
| 191 | VTYX | Ventyx Biosciences, Inc. | 669.34M | -6.20% | 1,119,386 | - |
| 192 | LXEO | Lexeo Therapeutics, Inc. | 651.05M | -9.53% | 1,072,876 | - |
| 193 | RGNX | REGENXBIO Inc. | 637.85M | -5.90% | 523,733 | 161.32M |
| 194 | CRVS | Corvus Pharmaceuticals, Inc. | 635.54M | -7.20% | 888,267 | - |
| 195 | CGEM | Cullinan Therapeutics, Inc. | 635.07M | -5.45% | 1,611,461 | - |
| 196 | MGTX | MeiraGTx Holdings plc | 631.05M | -5.54% | 435,427 | 27.42M |
| 197 | EVMN | Evommune, Inc. | 628.92M | 0.97% | 153,364 | 3.00M |
| 198 | PRME | Prime Medicine, Inc. | 619.63M | -8.38% | 2,667,781 | 5.98M |
| 199 | ANNX | Annexon, Inc. | 615.60M | -8.22% | 2,239,405 | - |
| 200 | FDMT | 4D Molecular Therapeutics, Inc. | 600.49M | -9.86% | 899,499 | 120.00K |
| 201 | IVA | Inventiva S.A. | 595.30M | 2.35% | 216,935 | 19.93M |
| 202 | MPLT | MapLight Therapeutics, Inc. | 593.09M | -0.29% | 156,237 | - |
| 203 | IVVD | Invivyd, Inc. | 582.81M | 2.88% | 6,613,232 | 50.04M |
| 204 | MNPR | Monopar Therapeutics Inc. | 556.75M | -3.33% | 100,671 | - |
| 205 | JBIO | Jade Biosciences, Inc. | 556.65M | -5.62% | 102,125 | - |
| 206 | PRTA | Prothena Corporation plc | 552.83M | -4.47% | 648,475 | 11.79M |
| 207 | ASMB | Assembly Biosciences, Inc. | 536.04M | -10.32% | 146,374 | 37.19M |
| 208 | NAGE | Niagen Bioscience, Inc. | 534.19M | -1.48% | 900,729 | 124.71M |
| 209 | FULC | Fulcrum Therapeutics, Inc. | 534.15M | -9.78% | 815,491 | 80.00M |
| 210 | DRUG | Bright Minds Biosciences Inc. | 532.55M | 0.36% | 104,997 | - |
| 211 | ADCT | ADC Therapeutics SA | 525.24M | -1.40% | 563,237 | 75.21M |
| 212 | KROS | Keros Therapeutics, Inc. | 523.41M | -1.72% | 789,266 | 246.72M |
| 213 | ALT | Altimmune, Inc. | 514.41M | -6.27% | 4,372,684 | 20.00K |
| 214 | ENGN | enGene Holdings Inc. | 513.72M | -1.43% | 297,985 | - |
| 215 | DSGN | Design Therapeutics, Inc. | 509.83M | -4.69% | 142,861 | - |
| 216 | LXRX | Lexicon Pharmaceuticals, Inc. | 494.22M | -4.90% | 1,295,918 | 70.86M |
| 217 | DNA | Ginkgo Bioworks Holdings, Inc. | 491.63M | -6.79% | 876,623 | 180.61M |
| 218 | BCYC | Bicycle Therapeutics plc | 489.74M | -5.61% | 303,985 | 28.34M |
| 219 | DBVT | DBV Technologies S.A. | 480.40M | -0.84% | 395,402 | 5.50M |
| 220 | ZVRA | Zevra Therapeutics, Inc. | 469.52M | -1.07% | 1,211,471 | 84.39M |
| 221 | LYEL | Lyell Immunopharma, Inc. | 468.92M | -7.92% | 51,561 | 41.00K |
| 222 | IMRX | Immuneering Corporation | 457.80M | -7.44% | 847,191 | - |
| 223 | ABSI | Absci Corporation | 457.13M | -4.10% | 3,599,466 | 2.82M |
| 224 | NBP | NovaBridge Biosciences | 442.62M | - | 356,563 | - |
| 225 | LBRX | LB Pharmaceuticals Inc | 438.94M | -2.47% | 204,241 | - |
| 226 | DMAC | DiaMedica Therapeutics Inc. | 426.51M | -5.10% | 385,982 | - |
| 227 | BNTC | Benitec Biopharma Inc. | 413.46M | -5.79% | 138,001 | - |
| 228 | ENTA | Enanta Pharmaceuticals, Inc. | 408.12M | 0.14% | 432,820 | 65.32M |
| 229 | SLDB | Solid Biosciences Inc. | 405.91M | -4.05% | 1,316,060 | - |
| 230 | ANRO | Alto Neuroscience, Inc. | 405.11M | -5.85% | 245,939 | - |
| 231 | NMRA | Neumora Therapeutics, Inc. | 404.36M | 8.04% | 2,307,358 | - |
| 232 | PRTC | PureTech Health plc | 403.11M | 0.54% | 967 | 6.39M |
| 233 | LCTX | Lineage Cell Therapeutics, Inc. | 402.26M | -5.68% | 2,773,325 | 10.82M |
| 234 | PEPG | PepGen Inc. | 398.05M | -10.09% | 672,110 | - |
| 235 | AURA | Aura Biosciences, Inc. | 394.36M | -5.91% | 153,656 | - |
| 236 | XOMA | XOMA Royalty Corporation | 384.87M | -3.27% | 54,543 | 47.11M |
| 237 | TECX | Tectonic Therapeutic, Inc. | 383.12M | -4.52% | 260,958 | - |
| 238 | OCGN | Ocugen, Inc. | 368.54M | -4.84% | 3,189,251 | 5.37M |
| 239 | TENX | Tenax Therapeutics, Inc. | 367.97M | -3.82% | 112,534 | - |
| 240 | AUTL | Autolus Therapeutics plc | 367.28M | -2.13% | 2,658,702 | 51.13M |
| 241 | TRDA | Entrada Therapeutics, Inc. | 355.39M | -3.51% | 225,632 | 61.52M |
| 242 | GALT | Galectin Therapeutics Inc. | 355.25M | -3.84% | 237,982 | - |
| 243 | RCKT | Rocket Pharmaceuticals, Inc. | 341.98M | -7.60% | 2,750,093 | - |
| 244 | AVXL | Anavex Life Sciences Corp. | 341.31M | -0.26% | 3,073,596 | - |
| 245 | CLLS | Cellectis S.A. | 340.94M | -8.87% | 135,019 | 82.55M |
| 246 | RLMD | Relmada Therapeutics, Inc. | 324.13M | -2.00% | 902,382 | - |
| 247 | FBRX | Forte Biosciences, Inc. | 324.09M | -2.07% | 53,798 | - |
| 248 | DRTS | Alpha Tau Medical Ltd. | 322.30M | -4.79% | 48,907 | - |
| 249 | CTNM | Contineum Therapeutics, Inc. | 319.84M | -0.99% | 133,733 | - |
| 250 | NGNE | Neurogene Inc. | 317.23M | -2.85% | 262,117 | 925.00K |
| 251 | EPRX | Eupraxia Pharmaceuticals Inc. | 316.49M | -2.58% | 39,931 | - |
| 252 | ALDX | Aldeyra Therapeutics, Inc. | 315.25M | -4.38% | 869,331 | - |
| 253 | SLN | Silence Therapeutics plc | 311.74M | -2.08% | 359,361 | 25.83M |
| 254 | ALLO | Allogene Therapeutics, Inc. | 307.88M | -6.16% | 1,950,172 | 22.00K |
| 255 | AVTX | Avalo Therapeutics, Inc. | 304.29M | -11.68% | 507,956 | 192.00K |
| 256 | CAPR | Capricor Therapeutics, Inc. | 304.03M | 24.30% | 6,355,971 | 11.13M |
| 257 | LRMR | Larimar Therapeutics, Inc. | 303.85M | 0.28% | 3,339,975 | - |
| 258 | CYBN | Cybin Inc. | 299.42M | -2.91% | 464,495 | - |
| 259 | VNDA | Vanda Pharmaceuticals Inc. | 296.67M | -6.34% | 669,511 | 212.07M |
| 260 | KYTX | Kyverna Therapeutics, Inc. | 294.75M | -12.26% | 630,025 | - |
| 261 | MREO | Mereo BioPharma Group plc | 292.80M | -1.60% | 2,008,408 | 500.00K |
| 262 | VTVT | vTv Therapeutics Inc. | 291.61M | -11.99% | 15,316 | 17.00K |
| 263 | IMMP | Immutep Limited | 284.47M | -2.96% | 74,134 | 3.31M |
| 264 | ACRS | Aclaris Therapeutics, Inc. | 282.78M | -7.77% | 1,207,311 | 15.74M |
| 265 | OBIO | Orchestra BioMed Holdings, Inc. | 282.32M | -6.02% | 242,831 | 2.82M |
| 266 | CBIO | Crescent Biopharma, Inc. | 278.97M | -5.18% | 11,160 | - |
| 267 | PALI | Palisade Bio, Inc. | 278.64M | -11.37% | 4,573,955 | - |
| 268 | XFOR | X4 Pharmaceuticals, Inc. | 275.43M | -13.46% | 1,339,237 | 33.98M |
| 269 | PYXS | Pyxis Oncology, Inc. | 273.34M | -15.41% | 1,019,397 | 2.82M |
| 270 | MIST | Milestone Pharmaceuticals Inc. | 273.26M | - | 4,553,151 | - |
| 271 | ACIU | AC Immune SA | 271.10M | -8.36% | 161,651 | 5.48M |
| 272 | FENC | Fennec Pharmaceuticals Inc. | 264.35M | -5.49% | 189,062 | 38.79M |
| 273 | TARA | Protara Therapeutics, Inc. | 260.08M | -8.67% | 759,283 | - |
| 274 | ABEO | Abeona Therapeutics Inc. | 259.03M | -5.72% | 1,221,668 | 400.00K |
| 275 | NAUT | Nautilus Biotechnology, Inc. | 250.08M | -12.00% | 479,978 | - |
| 276 | PBYI | Puma Biotechnology, Inc. | 249.94M | -1.78% | 315,581 | 212.00M |
| 277 | OABI | OmniAb, Inc. | 249.76M | -4.14% | 335,776 | 21.09M |
| 278 | FHTX | Foghorn Therapeutics Inc. | 248.83M | -7.37% | 236,356 | 24.52M |
| 279 | ACHV | Achieve Life Sciences, Inc. | 247.54M | -4.52% | 458,062 | - |
| 280 | CCCC | C4 Therapeutics, Inc. | 246.16M | -6.27% | 1,270,566 | 30.11M |
| 281 | ARMP | Armata Pharmaceuticals, Inc. | 245.95M | -7.64% | 59,313 | 5.05M |
| 282 | CADL | Candel Therapeutics, Inc. | 245.67M | -6.18% | 817,130 | - |
| 283 | ZURA | Zura Bio Limited | 241.89M | -3.12% | 354,931 | - |
| 284 | AVIR | Atea Pharmaceuticals, Inc. | 241.41M | -0.32% | 265,403 | - |
| 285 | HUMA | Humacyte, Inc. | 239.71M | -5.19% | 3,767,001 | 1.57M |
| 286 | CABA | Cabaletta Bio, Inc. | 233.92M | -5.45% | 1,574,879 | - |
| 287 | PRQR | ProQR Therapeutics N.V. | 223.33M | -9.40% | 276,178 | 18.86M |
| 288 | SGMT | Sagimet Biosciences Inc. | 221.15M | -5.82% | 395,505 | - |
| 289 | MDWD | MediWound Ltd. | 220.02M | -4.24% | 67,927 | 20.93M |
| 290 | VYGR | Voyager Therapeutics, Inc. | 219.62M | -3.42% | 634,875 | 31.32M |
| 291 | BDTX | Black Diamond Therapeutics, Inc. | 214.80M | -1.31% | 858,102 | 70.00M |
| 292 | GUTS | Fractyl Health, Inc. | 213.79M | -0.64% | 2,935,664 | 3.00K |
| 293 | EDIT | Editas Medicine, Inc. | 213.78M | -9.13% | 1,676,975 | 46.38M |
| 294 | SLS | SELLAS Life Sciences Group, Inc. | 213.66M | -7.41% | 2,582,776 | - |
| 295 | TNYA | Tenaya Therapeutics, Inc. | 213.13M | -8.57% | 1,596,713 | - |
| 296 | TLSA | Tiziana Life Sciences Ltd | 212.69M | -0.56% | 348,793 | - |
| 297 | HRTX | Heron Therapeutics, Inc. | 210.87M | -0.86% | 2,565,777 | 155.10M |
| 298 | AARD | Aardvark Therapeutics, Inc. | 207.28M | -4.61% | 205,241 | - |
| 299 | ETHZ | ETHZilla Corporation | 202.65M | -11.33% | 1,337,942 | 4.11M |
| 300 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 199.18M | -6.85% | 187,414 | - |
| 301 | RNAC | Cartesian Therapeutics, Inc. | 189.83M | -2.54% | 233,446 | 1.09M |
| 302 | IPHA | Innate Pharma S.A. | 185.15M | -0.51% | 31,637 | 14.84M |
| 303 | ARCT | Arcturus Therapeutics Holdings Inc. | 184.40M | -4.42% | 720,603 | 97.60M |
| 304 | GNLX | Genelux Corporation | 184.33M | -11.87% | 551,026 | 8.00K |
| 305 | SABS | SAB Biotherapeutics, Inc. | 180.43M | -3.80% | 367,286 | 114.70K |
| 306 | RANI | Rani Therapeutics Holdings, Inc. | 179.84M | -7.50% | 2,198,597 | 1.20M |
| 307 | TNXP | Tonix Pharmaceuticals Holding Corp. | 179.24M | -4.70% | 404,119 | 10.30M |
| 308 | QNCX | Quince Therapeutics, Inc. | 176.51M | -13.15% | 1,676,503 | - |
| 309 | VTGN | Vistagen Therapeutics, Inc. | 174.96M | -9.59% | 655,549 | 721.00K |
| 310 | ACTU | Actuate Therapeutics, Inc. | 166.65M | -6.03% | 99,287 | - |
| 311 | NTHI | NeOnc Technologies Holdings, Inc. | 166.12M | -4.69% | 30,674 | 59.99K |
| 312 | CRBU | Caribou Biosciences, Inc. | 165.44M | -8.76% | 1,158,956 | 9.30M |
| 313 | ELTX | Elicio Therapeutics, Inc. | 157.10M | -3.95% | 116,831 | - |
| 314 | MCRB | Seres Therapeutics, Inc. | 156.87M | -3.61% | 76,820 | 351.00K |
| 315 | VOR | Vor Biopharma Inc. | 156.75M | -7.80% | 426,979 | - |
| 316 | CNTB | Connect Biopharma Holdings Limited | 154.85M | -1.42% | 157,675 | 762.00K |
| 317 | CHRS | Coherus Oncology, Inc. | 153.51M | -6.62% | 802,808 | 277.73M |
| 318 | STTK | Shattuck Labs, Inc. | 152.50M | 14.76% | 1,132,039 | 1.00M |
| 319 | NVCT | Nuvectis Pharma, Inc. | 152.15M | -4.81% | 109,498 | - |
| 320 | CAMP | Camp4 Therapeutics Corporation | 151.89M | -14.74% | 81,917 | 3.80M |
| 321 | CDXS | Codexis, Inc. | 149.04M | -4.62% | 984,411 | 52.93M |
| 322 | AGEN | Agenus Inc. | 146.92M | -5.26% | 599,372 | 106.83M |
| 323 | SAVA | Cassava Sciences, Inc. | 146.37M | -6.77% | 861,557 | - |
| 324 | CRDF | Cardiff Oncology, Inc. | 146.17M | -4.82% | 471,981 | 501.00K |
| 325 | ANIX | Anixa Biosciences, Inc. | 144.83M | -4.14% | 128,080 | - |
| 326 | MOLN | Molecular Partners AG | 143.24M | -2.47% | 2,663 | 856.30K |
| 327 | SGMO | Sangamo Therapeutics, Inc. | 143.14M | -7.72% | 3,230,362 | 32.88M |
| 328 | CGTX | Cognition Therapeutics, Inc. | 142.12M | -7.47% | 1,225,060 | - |
| 329 | CGEN | Compugen Ltd. | 139.84M | -4.17% | 403,641 | 6.90M |
| 330 | SRZN | Surrozen, Inc. | 138.17M | -2.77% | 140,335 | 3.60M |
| 331 | IRD | Opus Genetics, Inc. | 137.93M | -6.10% | 222,085 | 14.63M |
| 332 | NBY | NovaBay Pharmaceuticals, Inc. | 137.35M | - | 61,035 | 10.30M |
| 333 | MRSN | Mersana Therapeutics, Inc. | 137.22M | 0.07% | 64,951 | 33.18M |
| 334 | PLX | Protalix BioTherapeutics, Inc. | 136.72M | -4.49% | 712,936 | 61.84M |
| 335 | IMMX | Immix Biopharma, Inc. | 135.32M | -5.18% | 332,303 | - |
| 336 | ALEC | Alector, Inc. | 134.26M | -7.52% | 1,214,001 | 69.05M |
| 337 | INO | Inovio Pharmaceuticals, Inc. | 131.91M | -6.80% | 1,056,602 | 182.34K |
| 338 | COYA | Coya Therapeutics, Inc. | 130.05M | -4.53% | 119,648 | 3.99M |
| 339 | EXOZ | eXoZymes, Inc. | 129.46M | -2.74% | 1,538 | -700.00 |
| 340 | UNCY | Unicycive Therapeutics, Inc. | 128.95M | -7.26% | 449,070 | - |
| 341 | NKTX | Nkarta, Inc. | 128.56M | -4.23% | 863,451 | - |
| 342 | OVID | Ovid Therapeutics Inc. | 128.18M | 1.12% | 3,210,593 | 6.61M |
| 343 | SPRO | Spero Therapeutics, Inc. | 127.89M | -5.42% | 367,479 | 40.55M |
| 344 | PRLD | Prelude Therapeutics Incorporated | 127.72M | -7.74% | 252,975 | 10.50M |
| 345 | ACOG | Alpha Cognition Inc. | 123.93M | -5.32% | 98,324 | 7.43M |
| 346 | CLYM | Climb Bio, Inc. | 122.05M | -5.29% | 304,282 | - |
| 347 | ANVS | Annovis Bio, Inc. | 119.53M | -11.57% | 1,854,145 | - |
| 348 | DTIL | Precision BioSciences, Inc. | 119.40M | -8.82% | 153,903 | 698.00K |
| 349 | FATE | Fate Therapeutics, Inc. | 118.81M | -9.65% | 1,403,136 | 7.14M |
| 350 | GANX | Gain Therapeutics, Inc. | 117.42M | -7.43% | 1,119,728 | - |
| 351 | ABOS | Acumen Pharmaceuticals, Inc. | 115.09M | 1.06% | 133,712 | - |
| 352 | ELDN | Eledon Pharmaceuticals, Inc. | 114.98M | -6.13% | 1,007,619 | - |
| 353 | GLSI | Greenwich LifeSciences, Inc. | 114.16M | -5.61% | 49,987 | - |
| 354 | CNTX | Context Therapeutics Inc. | 114.05M | -4.46% | 142,344 | - |
| 355 | IKT | Inhibikase Therapeutics, Inc. | 112.76M | -1.32% | 291,946 | 1.00 |
| 356 | ORMP | Oramed Pharmaceuticals Inc. | 109.46M | -3.51% | 119,918 | 2.00M |
| 357 | SLGL | Sol-Gel Technologies Ltd. | 107.73M | -8.83% | 48,085 | 18.97M |
| 358 | WHWK | Whitehawk Therapeutics, Inc. | 106.51M | -3.42% | 337,390 | 14.38M |
| 359 | SEER | Seer, Inc. | 106.00M | -1.04% | 89,176 | 16.38M |
| 360 | ENTX | Entera Bio Ltd. | 105.01M | -3.78% | 46,176 | 124.00K |
| 361 | TTRX | Turn Therapeutics Inc. | 103.06M | -0.57% | 29,375 | - |
| 362 | KLRS | Kalaris Therapeutics, Inc. | 101.93M | -12.66% | 137,843 | - |
| 363 | ONCY | Oncolytics Biotech Inc. | 99.78M | -5.70% | 896,078 | - |
| 364 | ZNTL | Zentalis Pharmaceuticals, Inc. | 98.98M | -4.20% | 363,839 | 26.87M |
| 365 | ACET | Adicet Bio, Inc. | 98.69M | -5.85% | 1,494,085 | - |
| 366 | KPTI | Karyopharm Therapeutics Inc. | 98.04M | 2.31% | 256,797 | 142.53M |
| 367 | ATRA | Atara Biotherapeutics, Inc. | 97.63M | -10.33% | 86,889 | 151.93M |
| 368 | VANI | Vivani Medical, Inc. | 97.03M | -2.21% | 80,182 | - |
| 369 | ANEB | Anebulo Pharmaceuticals, Inc. | 96.96M | 0.85% | 6,117 | - |
| 370 | ATOS | Atossa Therapeutics, Inc. | 95.85M | -4.57% | 743,822 | - |
| 371 | HURA | TuHURA Biosciences, Inc. | 94.31M | -8.00% | 129,965 | - |
| 372 | PLRX | Pliant Therapeutics, Inc. | 94.02M | -4.97% | 640,258 | - |
| 373 | ADVM | Adverum Biotechnologies, Inc. | 92.73M | 1.94% | 864,685 | 1.00M |
| 374 | MGNX | MacroGenics, Inc. | 92.67M | -4.25% | 454,017 | 127.63M |
| 375 | RPTX | Repare Therapeutics Inc. | 91.56M | -2.29% | 466,796 | 11.87M |
| 376 | VXRT | Vaxart, Inc. | 90.91M | 2.57% | - | 148.20M |
| 377 | COEP | Coeptis Therapeutics Holdings, Inc. | 90.09M | -9.93% | 60,907 | 501.00K |
| 378 | SPRB | Spruce Biosciences, Inc. | 88.96M | -16.89% | 527,585 | 697.00K |
| 379 | ADAG | Adagene Inc. | 88.61M | -6.47% | 63,071 | 103.20K |
| 380 | CRVO | CervoMed Inc. | 85.31M | -7.24% | 70,702 | 6.16M |
| 381 | ARTV | Artiva Biotherapeutics, Inc. | 85.17M | -7.71% | 191,698 | 251.00K |
| 382 | FBIO | Fortress Biotech, Inc. | 84.58M | -3.55% | 329,643 | 62.30M |
| 383 | HYFT | MindWalk Holdings Corp. | 84.46M | -11.17% | 338,579 | 18.21M |
| 384 | BYSI | BeyondSpring Inc. | 84.30M | -3.30% | 14,593 | 1.88M |
| 385 | CSBR | Champions Oncology, Inc. | 82.73M | -8.26% | 14,473 | 56.88M |
| 386 | THAR | Tharimmune, Inc. | 82.71M | -9.23% | 129,808 | - |
| 387 | OTLK | Outlook Therapeutics, Inc. | 82.62M | 3.91% | 1,484,905 | 1.51M |
| 388 | IMUX | Immunic, Inc. | 81.67M | -4.62% | 1,526,730 | - |
| 389 | PTHS | Pelthos Therapeutics Inc. | 81.01M | -6.83% | 32,547 | 7.41M |
| 390 | TVGN | Tevogen Bio Holdings Inc. | 80.33M | -8.36% | 497,782 | - |
| 391 | PSTV | Plus Therapeutics, Inc. | 80.11M | -4.44% | 5,075,229 | 5.26M |
| 392 | CBUS | Cibus, Inc. | 79.80M | 8.09% | 229,174 | 3.79M |
| 393 | IFRX | InflaRx N.V. | 78.59M | -7.94% | 866,395 | 73.73K |
| 394 | TIL | Instil Bio, Inc. | 77.59M | -10.34% | 50,540 | - |
| 395 | ACRV | Acrivon Therapeutics, Inc. | 76.36M | 2.54% | 565,124 | - |
| 396 | XBIT | XBiotech Inc. | 73.48M | 6.17% | 149,688 | - |
| 397 | ATYR | aTyr Pharma, Inc. | 72.62M | -5.05% | 2,459,226 | 190.00K |
| 398 | VRCA | Verrica Pharmaceuticals Inc. | 71.65M | -17.03% | 848,777 | 30.83M |
| 399 | ALXO | ALX Oncology Holdings Inc. | 71.57M | -3.65% | 193,465 | - |
| 400 | BMEA | Biomea Fusion, Inc. | 71.41M | -7.34% | 859,730 | - |
| 401 | IMA | ImageneBio, Inc. | 71.36M | -2.90% | 113,440 | 800.00K |
| 402 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 70.96M | 9.64% | 8,183,278 | - |
| 403 | OKYO | OKYO Pharma Limited | 69.96M | -5.10% | 91,383 | - |
| 404 | MNOV | MediciNova, Inc. | 69.16M | -2.76% | 52,807 | 257.92K |
| 405 | PMVP | PMV Pharmaceuticals, Inc. | 68.64M | -2.27% | 277,445 | - |
| 406 | STRO | Sutro Biopharma, Inc. | 68.24M | -12.82% | 2,243,606 | 105.65M |
| 407 | ESLA | Estrella Immunopharma, Inc. | 67.98M | -14.69% | 179,950 | - |
| 408 | NRXP | NRx Pharmaceuticals, Inc. | 67.15M | -2.45% | 507,274 | 242.00K |
| 409 | PYPD | PolyPid Ltd. | 64.21M | -2.28% | 128,754 | - |
| 410 | ATHE | Alterity Therapeutics Limited | 64.12M | -9.17% | 28,924 | 3.57M |
| 411 | LITS | Lite Strategy, Inc. | 62.90M | -9.52% | 314,968 | - |
| 412 | ABVC | ABVC BioPharma, Inc. | 62.46M | -2.21% | 30,076 | 797.92K |
| 413 | CALC | CalciMedica, Inc. | 61.82M | 0.47% | 35,462 | - |
| 414 | OSTX | OS Therapies Incorporated | 60.22M | -4.47% | 195,500 | - |
| 415 | MGX | Metagenomi, Inc. | 60.07M | -8.57% | 623,929 | 30.91M |
| 416 | NTRB | Nutriband Inc. | 59.36M | -0.10% | 11,693 | 2.58M |
| 417 | TCRX | TScan Therapeutics, Inc. | 57.88M | -8.11% | 816,441 | 8.42M |
| 418 | ALGS | Aligos Therapeutics, Inc. | 57.66M | -2.19% | 114,035 | 2.65M |
| 419 | CELU | Celularity Inc. | 56.66M | - | 34,247 | 40.58M |
| 420 | CVM | CEL-SCI Corporation | 55.39M | -9.65% | 66,067 | - |
| 421 | ANL | Adlai Nortye Ltd. | 54.24M | -7.55% | 15,336 | 1.94M |
| 422 | SNTI | Senti Biosciences, Inc. | 54.16M | -7.62% | 86,762 | - |
| 423 | EQ | Equillium, Inc. | 52.37M | -4.70% | 201,392 | 4.39M |
| 424 | INKT | MiNK Therapeutics, Inc. | 52.06M | 5.52% | 18,947 | - |
| 425 | KRRO | Korro Bio, Inc. | 50.67M | -5.61% | 346,759 | 7.37M |
| 426 | IOBT | IO Biotech, Inc. | 49.07M | -5.23% | 1,199,580 | - |
| 427 | IBO | Impact BioMedical Inc. | 48.18M | 3.25% | 276,714 | 25.00K |
| 428 | JSPR | Jasper Therapeutics, Inc. | 48.13M | -6.52% | 2,011,465 | - |
| 429 | IPSC | Century Therapeutics, Inc. | 47.35M | -0.55% | 1,019,991 | 113.34M |
| 430 | GNTA | Genenta Science S.p.A. | 47.33M | 0.50% | 81,444 | - |
| 431 | QTTB | Q32 Bio Inc. | 47.00M | 74.43% | 167,914,229 | - |
| 432 | CUE | Cue Biopharma, Inc. | 46.85M | -5.56% | 252,426 | 7.10M |
| 433 | BCAB | BioAtla, Inc. | 46.55M | -12.41% | 2,116,432 | 11.00M |
| 434 | KZR | Kezar Life Sciences, Inc. | 45.55M | 0.32% | 24,855 | - |
| 435 | EVAX | Evaxion A/S | 45.13M | -8.42% | 58,945 | 7.65M |
| 436 | BTAI | BioXcel Therapeutics, Inc. | 45.05M | -8.44% | 565,675 | 752.00K |
| 437 | NXTC | NextCure, Inc. | 45.00M | -5.75% | 36,295 | - |
| 438 | GRCE | Grace Therapeutics, Inc. | 44.79M | -0.31% | 33,758 | - |
| 439 | HOWL | Werewolf Therapeutics, Inc. | 44.50M | -8.32% | 638,958 | 1.14M |
| 440 | MAIA | MAIA Biotechnology, Inc. | 44.44M | 1.69% | 4,070,393 | - |
| 441 | TELO | Telomir Pharmaceuticals, Inc. | 44.35M | -3.73% | 240,463 | - |
| 442 | ICCC | ImmuCell Corporation | 43.15M | -1.45% | 11,756 | 27.77M |
| 443 | ATNM | Actinium Pharmaceuticals, Inc. | 42.74M | -0.72% | 382,721 | 90.00K |
| 444 | RADX | Radiopharm Theranostics Limited | 41.88M | -1.32% | 4,214 | 8.20M |
| 445 | INMB | INmune Bio, Inc. | 41.61M | -10.06% | 631,428 | 50.00K |
| 446 | SER | Serina Therapeutics, Inc. | 41.59M | -8.45% | 16,198 | 116.00K |
| 447 | JUNS | Jupiter Neurosciences, Inc. | 41.31M | -2.04% | 25,405 | - |
| 448 | RNTX | Rein Therapeutics Inc. | 39.43M | -4.46% | 145,714 | - |
| 449 | PDSB | PDS Biotechnology Corporation | 39.27M | -6.91% | 485,241 | - |
| 450 | LTRN | Lantern Pharma Inc. | 39.20M | -3.18% | 22,583 | - |
| 451 | XLO | Xilio Therapeutics, Inc. | 38.82M | -2.39% | 217,053 | 31.80M |
| 452 | SKYE | Skye Bioscience, Inc. | 38.79M | -7.63% | 226,529 | - |
| 453 | VERU | Veru Inc. | 38.52M | -3.23% | 53,499 | 16.89M |
| 454 | OKUR | OnKure Therapeutics, Inc. | 38.48M | -5.65% | 207,727 | - |
| 455 | QNTM | Quantum BioPharma Ltd. | 38.39M | -11.65% | 169,872 | - |
| 456 | TVRD | Tvardi Therapeutics, Inc. | 36.82M | -4.73% | 89,571 | - |
| 457 | MURA | Mural Oncology plc | 35.21M | - | 99,107 | - |
| 458 | APLT | Applied Therapeutics, Inc. | 34.81M | -7.23% | 4,442,188 | 1.00M |
| 459 | FGEN | FibroGen, Inc. | 34.51M | -3.07% | 15,747 | 8.30M |
| 460 | GBIO | Generation Bio Co. | 34.36M | -4.32% | 12,544 | 15.27M |
| 461 | XCUR | Exicure, Inc. | 34.29M | 28.71% | 142,192 | 500.00K |
| 462 | DYAI | Dyadic International, Inc. | 33.65M | -1.78% | 7,176,652 | 3.34M |
| 463 | RNXT | RenovoRx, Inc. | 31.41M | -6.59% | 182,453 | 928.00K |
| 464 | KLTO | Klotho Neurosciences, Inc. | 31.33M | -9.11% | 571,941 | - |
| 465 | BRNS | Barinthus Biotherapeutics plc | 31.23M | -3.19% | 12,788 | 14.97M |
| 466 | PLUR | Pluri Inc. | 31.19M | -10.64% | 73,797 | 1.33M |
| 467 | LNAI | Lunai Bioworks Inc. | 30.70M | 11.02% | 786,131 | - |
| 468 | APLM | Apollomics, Inc. | 30.07M | -6.91% | 51,416 | 198.00K |
| 469 | NRSN | NeuroSense Therapeutics Ltd. | 29.30M | -1.68% | 166,866 | - |
| 470 | IGC | IGC Pharma, Inc. | 29.25M | -1.28% | 228,562 | 1.11M |
| 471 | ANTX | AN2 Therapeutics, Inc. | 29.05M | -2.75% | 93,106 | - |
| 472 | NRXS | NeurAxis, Inc. | 28.44M | -3.96% | 30,224 | 3.36M |
| 473 | RLYB | Rallybio Corporation | 27.37M | -0.51% | 78,044 | 674.00K |
| 474 | NERV | Minerva Neurosciences, Inc. | 26.99M | -7.66% | 82,629 | - |
| 475 | CLGN | CollPlant Biotechnologies Ltd. | 26.83M | -4.01% | 39,737 | 2.48M |
| 476 | HYPD | Hyperion DeFi, Inc. | 26.50M | -17.96% | 276,518 | 345.32K |
| 477 | PASG | Passage Bio, Inc. | 26.13M | -6.91% | 13,940 | - |
| 478 | LIMN | Liminatus Pharma, Inc. | 26.13M | -7.18% | 172,187 | - |
| 479 | CTXR | Citius Pharmaceuticals, Inc. | 24.94M | -6.25% | 707,196 | - |
| 480 | IBIO | iBio, Inc. | 24.74M | -10.57% | 850,332 | 500.00K |
| 481 | CING | Cingulate Inc. | 24.46M | -2.95% | 53,866 | - |
| 482 | BOLD | Boundless Bio, Inc. | 24.40M | -6.84% | 181,690 | - |
| 483 | DARE | Daré Bioscience, Inc. | 23.86M | -9.24% | 91,920 | -57.13K |
| 484 | ITRM | Iterum Therapeutics plc | 23.81M | -1.96% | 878,662 | 390.00K |
| 485 | NEUP | Neuphoria Therapeutics Inc. | 23.71M | -2.43% | 52,258 | 15.65M |
| 486 | GLTO | Galecto, Inc. | 23.58M | -0.06% | 162,958 | - |
| 487 | LEXX | Lexaria Bioscience Corp. | 23.56M | -2.75% | 107,288 | 705.92K |
| 488 | LIXT | Lixte Biotechnology Holdings, Inc. | 23.39M | -3.98% | 28,271 | - |
| 489 | INTS | Intensity Therapeutics, Inc. | 22.84M | -4.78% | 1,272,890 | - |
| 490 | PTN | Palatin Technologies, Inc. | 22.39M | 2.20% | 77,807 | 8.85M |
| 491 | ENLV | Enlivex Therapeutics Ltd. | 22.33M | -5.25% | 728,300 | - |
| 492 | APVO | Aptevo Therapeutics Inc. | 22.24M | -4.35% | 500,698 | - |
| 493 | SONN | Sonnet BioTherapeutics Holdings, Inc. | 21.16M | -16.67% | 898,146 | 1.00M |
| 494 | GDTC | CytoMed Therapeutics Limited | 20.89M | -1.63% | 14,284 | 573.19K |
| 495 | CASI | CASI Pharmaceuticals, Inc. | 20.26M | -3.35% | 50,315 | 26.85M |
| 496 | NNVC | NanoViricides, Inc. | 20.16M | -8.20% | 493,105 | - |
| 497 | TRAW | Traws Pharma, Inc. | 19.82M | -8.15% | 301,467 | 2.85M |
| 498 | ALLR | Allarity Therapeutics, Inc. | 19.76M | -6.02% | 98,544 | - |
| 499 | MRKR | Marker Therapeutics, Inc. | 19.67M | -4.84% | 205,847 | 4.69M |
| 500 | BCTX | BriaCell Therapeutics Corp. | 19.19M | -0.92% | 22,033 | - |
| 501 | CVKD | Cadrenal Therapeutics, Inc. | 18.68M | -4.13% | 22,222 | - |
| 502 | LPCN | Lipocine Inc. | 18.54M | -2.91% | 8,765 | 4.32M |
| 503 | OSRH | OSR Holdings, Inc. | 18.27M | -4.34% | 753,841 | -90.52K |
| 504 | MTVA | MetaVia Inc. | 18.18M | -3.51% | 171,054 | - |
| 505 | LSTA | Lisata Therapeutics, Inc. | 17.73M | -2.43% | 23,454 | 1.07M |
| 506 | HOTH | Hoth Therapeutics, Inc. | 17.69M | -5.79% | 79,448 | - |
| 507 | ABP | Abpro Holdings, Inc. | 17.63M | -4.56% | 15,142 | 183.00K |
| 508 | KAPA | Kairos Pharma, Ltd. | 17.08M | -1.62% | 164,884 | - |
| 509 | NCEL | NewcelX Ltd. | 16.87M | -7.73% | 66,684 | - |
| 510 | KZIA | Kazia Therapeutics Limited | 16.79M | -13.27% | 159,338 | 1.20M |
| 511 | ATHA | Athira Pharma, Inc. | 16.76M | -2.30% | 37,282 | - |
| 512 | NCNA | NuCana plc | 16.65M | -6.54% | 39,654 | - |
| 513 | SYBX | Synlogic, Inc. | 16.50M | -3.42% | 13,873 | 8.00K |
| 514 | PULM | Pulmatrix, Inc. | 16.36M | 0.67% | 8,531 | 3.00K |
| 515 | CRIS | Curis, Inc. | 16.29M | -8.03% | 92,182 | 11.65M |
| 516 | QNRX | Quoin Pharmaceuticals, Ltd. | 16.24M | -10.99% | 39,108 | - |
| 517 | CMMB | Chemomab Therapeutics Ltd. | 16.19M | 0.38% | 55,699 | - |
| 518 | FBLG | FibroBiologics, Inc. | 16.00M | -4.74% | 1,320,009 | - |
| 519 | CANF | Can-Fite BioPharma Ltd. | 15.71M | 10.46% | 2,654,269 | 560.00K |
| 520 | CLRB | Cellectar Biosciences, Inc. | 15.62M | 3.90% | 62,464 | - |
| 521 | SNGX | Soligenix, Inc. | 15.33M | -4.40% | 258,408 | 2.34K |
| 522 | PCSA | Processa Pharmaceuticals, Inc. | 15.12M | 3.09% | 619,018 | - |
| 523 | PMN | ProMIS Neurosciences, Inc. | 15.07M | 3.55% | 85,636 | - |
| 524 | TPST | Tempest Therapeutics, Inc. | 15.03M | -4.69% | 132,351 | - |
| 525 | BCDA | BioCardia, Inc. | 14.75M | -4.14% | 44,701 | 3.00K |
| 526 | DWTX | Dogwood Therapeutics, Inc. | 14.56M | -2.61% | 12,813 | - |
| 527 | BLRX | BioLineRx Ltd. | 14.41M | -3.75% | 38,768 | 12.74M |
| 528 | AKTX | Akari Therapeutics, Plc | 14.37M | -17.33% | 233,502 | - |
| 529 | COCP | Cocrystal Pharma, Inc. | 14.20M | -2.83% | 46,979 | - |
| 530 | MBRX | Moleculin Biotech, Inc. | 13.50M | -2.75% | 262,722 | - |
| 531 | PHIO | Phio Pharmaceuticals Corp. | 13.46M | -0.79% | 143,446 | - |
| 532 | LGVN | Longeveron Inc. | 13.44M | -5.08% | 587,194 | 1.44M |
| 533 | IMRN | Immuron Limited | 13.10M | 1.17% | 28,039 | 4.78M |
| 534 | PPCB | Propanc Biopharma, Inc. | 12.60M | 5.47% | 3,168,460 | - |
| 535 | VYNE | VYNE Therapeutics Inc. | 12.16M | -5.19% | 621,975 | 524.00K |
| 536 | IMNN | Imunon, Inc. | 12.08M | -4.49% | 16,830 | - |
| 537 | EDSA | Edesa Biotech, Inc. | 12.03M | -2.29% | 62,679 | - |
| 538 | BIVI | BioVie Inc. | 11.34M | 0.33% | 43,803 | - |
| 539 | ICU | SeaStar Medical Holding Corporation | 11.32M | -0.82% | 1,595,487 | 881.00K |
| 540 | GOVX | GeoVax Labs, Inc. | 11.18M | -8.44% | 353,755 | 3.35M |
| 541 | KALA | KALA BIO, Inc. | 10.92M | 37.67% | 169,527,294 | - |
| 542 | CLDI | Calidi Biotherapeutics, Inc. | 10.83M | -1.99% | 77,914 | - |
| 543 | APM | Aptorum Group Limited | 10.67M | -2.96% | 35,064 | - |
| 544 | ASBP | Aspire Biopharma Holdings, Inc. | 10.62M | -6.53% | 10,015,466 | 1.94K |
| 545 | SNSE | Sensei Biotherapeutics, Inc. | 10.61M | -0.12% | 5,860 | - |
| 546 | ERNA | Ernexa Therapeutics Inc. | 9.81M | -7.41% | 64,546 | 1,000.00 |
| 547 | EVGN | Evogene Ltd. | 9.67M | -2.83% | 112,540 | 8.02M |
| 548 | BOLT | Bolt Biotherapeutics, Inc. | 9.53M | -2.08% | 21,665 | 5.20M |
| 549 | MBIO | Mustang Bio, Inc. | 9.49M | -7.80% | 69,584 | - |
| 550 | BRTX | BioRestorative Therapies, Inc. | 9.47M | -1.08% | 60,895 | 383.40K |
| 551 | AEON | AEON Biopharma, Inc. | 9.35M | -6.79% | 105,219 | - |
| 552 | CELZ | Creative Medical Technology Holdings, Inc. | 9.28M | -6.69% | 93,161 | 6.00K |
| 553 | INAB | IN8bio, Inc. | 9.04M | -1.52% | 68,064 | - |
| 554 | KTTA | Pasithea Therapeutics Corp. | 8.63M | -21.09% | 9,070,771 | - |
| 555 | RNAZ | TransCode Therapeutics, Inc. | 8.48M | -0.43% | 1,309 | - |
| 556 | GTBP | GT Biopharma, Inc. | 8.30M | -1.27% | 316,542 | - |
| 557 | BGMS | Bio Green Med Solution, Inc. | 8.13M | 9.93% | 121,229 | 81.00K |
| 558 | ADXN | Addex Therapeutics Ltd | 8.01M | 6.99% | 69,977 | 210.35K |
| 559 | ALZN | Alzamend Neuro, Inc. | 7.95M | -4.57% | 58,883 | - |
| 560 | XTLB | XTL Biopharmaceuticals Ltd. | 7.85M | 3.51% | 73,592 | 451.00K |
| 561 | ADIL | Adial Pharmaceuticals, Inc. | 7.51M | -0.19% | 154,802 | - |
| 562 | ACXP | Acurx Pharmaceuticals, Inc. | 7.49M | -7.47% | 41,032 | - |
| 563 | TOVX | Theriva Biologics, Inc. | 7.39M | -18.90% | 3,769,882 | - |
| 564 | KPRX | Kiora Pharmaceuticals, Inc. | 7.08M | -2.53% | 121,499 | 20.00K |
| 565 | APRE | Aprea Therapeutics, Inc. | 7.00M | -11.90% | 85,591 | 488.24K |
| 566 | PPBT | Purple Biotech Ltd | 6.66M | 5.82% | 457,071 | - |
| 567 | TCRT | Alaunos Therapeutics, Inc. | 6.65M | -10.78% | 161,143 | 6.00K |
| 568 | LYRA | Lyra Therapeutics, Inc. | 6.62M | 1.08% | 28,995 | 600.00K |
| 569 | PHGE | BiomX Inc. | 6.46M | -2.98% | 67,959 | - |
| 570 | GRI | GRI Bio, Inc. | 6.44M | -1.50% | 91,962 | - |
| 571 | PLRZ | Polyrizon Ltd. | 6.24M | -1.56% | 76,948 | - |
| 572 | SILO | Silo Pharma, Inc. | 6.13M | -1.10% | 123,959 | 72.10K |
| 573 | CYCN | Cyclerion Therapeutics, Inc. | 5.94M | -1.27% | 22,755 | 2.86M |
| 574 | ENSC | Ensysce Biosciences, Inc. | 5.81M | -7.34% | 47,114 | 4.49M |
| 575 | VIVS | VivoSim Labs, Inc. | 5.71M | -2.23% | 12,798 | 140.00K |
| 576 | XBIO | Xenetic Biosciences, Inc. | 5.61M | -6.84% | 37,061 | 2.86M |
| 577 | REVB | Revelation Biosciences, Inc. | 5.59M | -1.15% | 35,489 | - |
| 578 | GLMD | Galmed Pharmaceuticals Ltd. | 5.34M | 3.66% | 232,636 | - |
| 579 | HCWB | HCW Biologics Inc. | 5.32M | -7.08% | 20,117 | 422.03K |
| 580 | CDIO | Cardio Diagnostics Holdings, Inc. | 5.28M | 0.35% | 6,164 | 15.78K |
| 581 | SLRX | Salarius Pharmaceuticals, Inc. | 5.10M | -7.41% | 264,365 | - |
| 582 | PMCB | PharmaCyte Biotech, Inc. | 5.10M | -3.06% | 369,824 | - |
| 583 | MTNB | Matinas BioPharma Holdings, Inc. | 4.99M | 3.87% | 29,400 | - |
| 584 | JAGX | Jaguar Health, Inc. | 4.81M | -12.96% | 95,526 | 11.79M |
| 585 | GNPX | Genprex, Inc. | 4.65M | -3.72% | 81,258 | - |
| 586 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 4.36M | -2.85% | 7,691 | 1.36M |
| 587 | CNSP | CNS Pharmaceuticals, Inc. | 4.27M | -0.86% | 2,093 | - |
| 588 | XRTX | XORTX Therapeutics Inc. | 4.21M | -5.54% | 23,613 | - |
| 589 | ONCO | Onconetix, Inc. | 4.12M | -5.04% | 20,695 | 1.22M |
| 590 | ELAB | PMGC Holdings Inc. | 3.92M | -0.75% | 12,626 | 285.95K |
| 591 | PTIX | Protagenic Therapeutics, Inc. | 3.77M | -8.45% | 151,540 | - |
| 592 | ARTL | Artelo Biosciences, Inc. | 3.69M | 5.17% | 8,959,186 | - |
| 593 | OGEN | Oragenics, Inc. | 3.50M | -3.45% | 58,171 | - |
| 594 | AZTR | Azitra, Inc. | 3.47M | -9.81% | 251,933 | 7.50K |
| 595 | INDP | Indaptus Therapeutics, Inc. | 3.41M | -12.56% | 53,614 | - |
| 596 | ENVB | Enveric Biosciences, Inc. | 3.41M | -0.35% | 6,358 | - |
| 597 | SCNI | Scinai Immunotherapeutics Ltd. | 3.19M | -2.91% | 67,117 | 1.15M |
| 598 | DRMA | Dermata Therapeutics, Inc. | 3.04M | -5.73% | 22,417 | - |
| 599 | PBM | Psyence Biomedical Ltd. | 3.03M | 5.54% | 213,924 | - |
| 600 | SPRC | SciSparc Ltd. | 2.98M | -16.36% | 471,477 | 1.31M |
| 601 | CMND | Clearmind Medicine Inc. | 2.97M | -6.92% | 20,412,428 | - |
| 602 | BDRX | Biodexa Pharmaceuticals Plc | 2.87M | 2.21% | 20,458 | 104.90K |
| 603 | CDT | CDT Equity Inc. | 2.66M | -19.70% | 245,793 | - |
| 604 | VRAX | Virax Biolabs Group Limited | 1.70M | -2.51% | 32,783 | 6.33K |
| 605 | MLEC | Moolec Science SA | 1.68M | 4.53% | 92,071 | 7.83M |
| 606 | ADTX | Aditxt, Inc. | 1.57M | -26.05% | 989,052 | 5.95K |
| 607 | SLXN | Silexion Therapeutics Corp | 1.55M | -2.47% | 26,897 | - |